Phio Pharmaceuticals CEO Robert J. Bitterman reports purchase of $10,600 in common shares

PUBT · 1d ago
Phio Pharmaceuticals CEO Robert J. Bitterman reports purchase of $10,600 in common shares
  • Phio Pharmaceuticals Chairman, President, CEO Robert J. Bitterman bought 10,000 common shares in an open-market purchase at USD 1.06 each.
  • Beneficial ownership increased to 431,421 common shares following the trade.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006592), on August 19, 2026, and is solely responsible for the information contained therein.